STOCKS SLIP AS WAIT FOR NVIDIA EARNINGS NEARS END

Target issues weak forecast as shoppers pull back on spending; shares tumble

AZN Jul 2024 75.000 call

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

5.45

0.00

(0.00%)

As of 02:42PM EDT. Market open.

Loading interactive chart...

Business Wire
AstraZeneca furthers ambition to transform outcomes in early lung cancer and redefine metastatic breast cancer treatment at ASCO 2024
WILMINGTON, Del., May 22, 2024--AstraZeneca advances its ambition to redefine cancer care with new data across its industry-leading portfolio and pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting, May 31 to June 4, 2024.
Zacks
AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
AstraZeneca (AZN) targets $80 billion in total revenues by 2030. It expects to launch 20 new medicines.
Investing.com
Midday movers: Microsoft, Xpeng rise; Palo Alto, Keysight fall
(Updated - May 21, 2024 11:56 AM EDT)